期刊文献+

甲状腺癌的多学科综合治疗的必要性及策略 被引量:5

The necessity and strategy of multidisciplinary team in management of thyroid carcinoma
原文传递
导出
摘要 TC是内分泌系统最常见的恶性肿瘤。单纯外科手术治疗不能满足TC的治疗要求。近年来,随着多学科综合治疗(muhidisciplinary team,MDT)概念的普及,我国临床肿瘤诊治的MDT建设进展迅速,对肿瘤诊治水平提高发挥了重要作用。MDT在对TC的诊断、治疗、术后管理、新技术应用及转化医学的研究方面,均扮演着重要角色。MDT模式可最大限度地发挥各学科专长、加强学科间协作,为TC患者提供规范化和个体化相统一的综合治疗。组建MDT对TC进行包括外科、内分泌科、核医学科、放疗、影像、病理等专科在内的会诊讨论,进行多学科综合治疗对提高患者生存质量,改善患者预后,同时避免过度治疗具有重要意义。 Thyroid carcinoma is the most common malignancy in the endocrine system. Most patients cannot be cured with operation alone. The concept and implementation of multidisciplinary team (MDT) in clinical oncology attributes to improved diagnosis and treatment of cancer. MDT plays an important role in diagnosis, treatment, and post operational management of thyroid carcinoma, as well as in the application of novel techniques and translational medicine. MDT can maximize the expertise of various disciplines, strengthen inter disciplinary cooperation, and provide standardized and individualized comprehensive treatment for patients with thyroid cancer. The most important benefit of MDT is that individual patient gets the most appropriate treatment decision made by a team of experts, including endocrinologists, nuclear medicine specialists, pathologists, radiologists, radiation therapists, and surgeons. This will be of great significance to improve quality of life and prognosis, at the same time, avoid over-treatment of thyroid cancer.
出处 《中华内分泌外科杂志》 CAS 2017年第1期1-3,共3页 Chinese Journal of Endocrine Surgery
基金 国家自然科学基金(81672641)
关键词 甲状腺癌 多学科综合治疗 Thyroid carcinoma Muhidisciplinary team
  • 相关文献

参考文献5

二级参考文献82

  • 1盛矢薇,朱瑞森,樊友本,高云朝,陆汉魁.^(99m)Tc-MIBI SPECT/CT对原发性甲状旁腺功能亢进症的诊断价值[J].上海交通大学学报(医学版),2011,31(10):1423-1427. 被引量:17
  • 2ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 3常绪生,樊友本.巨大甲状腺肿手术治疗的进展[J].国际外科学杂志,2007,34(3):192-195. 被引量:4
  • 4Williams Textbook of Endocrinology. 12th ed, 2011, Elsevier.
  • 5The American Thyroid Association ( ATA ) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer: Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2009,19 : 1167- 1214.
  • 6Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk [ J ]. Radiology, 2011,260 ( 3 ) : 892 -899.
  • 7Horvath E, Majlis S, Rossi R, et al. An uhrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical man- agement[ J]. J Clin Endocrinol Metab ,2009,94 (5) : 1748-1751.
  • 8Mehta V, Nikiforov YE, Ferris RL. Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgery[ J ]. Head Neck ,2013,35 (10) : 1499-1506.
  • 9Mazeh H. MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules [ J ]. Oncologist ,2012,17 (8) : 1032-1038.
  • 10Rossi M, Buratto M, Bruni S, et al. Role of ultrasonographic/ clinical profile, cytology, and BRAFV600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study [ J ]. J Clin Endocrinol Metab ,2012,97 (7) :2354-2361.

共引文献759

同被引文献30

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部